3 Weaknesses to Weigh Before You Buy Palantir (PLTR) Stock

Palantir trades at rich multiples—~142x this year’s earnings and a $370B market cap (~51x this year’s sales)—despite analysts forecasting 2025–2028 CAGRs of ~49% for revenue and ~54% for EPS. Key risks: controversial use of its Gotham platform may limit domestic and international expansion and throttle commercial growth; government contracts still comprised over half of 2025 revenue (government revenue rose 53% year-over-year but could fade as conflicts subside). Corporate signals include insiders selling >3x the shares they bought in the past three months and a 29% increase in share count over five years, which could constrain upside despite strong growth expectations.

Analysis

Palantir sits at an intersection of geopolitics, regulated-data use and the commercial AI adoption curve; the measurable second-order effect is procurement friction inside large enterprise buyers. Expect longer sales cycles (from typical SaaS 6–9 months to 12–18 months) and a 10–25% increase in upfront implementation discounts as legal/compliance reviews expand, which will compress near-term operating leverage even if ARR growth continues.

A pause or drawdown in defense-related demand would transmit to bookings within one to two contract renewal cycles (6–18 months) because multi-year government awards concentrate revenue and raise revenue visibility today but create cliff risk later. Separately, rapid LLM/AI model deployment materially increases customers’ cloud & GPU consumption; that raises Palantir’s cost-to-serve unless it negotiates pass-through pricing, creating a scenario where gross margins fall by several hundred basis points as commercial mix increases.

From a competitive standpoint, specialists that embed models into vertical workflows (healthcare claims, financial crime platforms) could gain share if large corporates prefer vendors without adverse policy baggage — an opportunity for pure-play software names or cloud-native analytics firms. The actionable implication is a two-part trade: protect downside tied to reputation/regulatory shocks while keeping asymmetric exposure to secular AI infrastructure winners that capture increased compute demand.

Key Decisions for Investors

• Buy a 6–12 month PLTR put spread (buy 1 30% OTM put / sell 1 45% OTM put) sized to limit premium to 0.5–1.0% of book value — objective: capture a 25–40% downside from regulatory/contract cliff within 9–12 months; max loss = premium paid, potential payoff 4–6x if move materializes.
• Pair trade: short PLTR equity 0.75x notional vs long NVDA equity 0.25x notional (net market beta neutral) for 12 months — this expresses de-rating risk in vendor-specific exposure while keeping asymmetric upside to GPU-driven AI demand; target 30% relative return, stop at 15% adverse relative move.
• Long NVDA 9–18 month call spread (buy 1 near-the-money / sell 1 +25% strike) sized 0.5–1.0% of portfolio to capture secular GPU tailwinds from enterprise model deployments; expect 2–4x return if adoption accelerates, limited downside to premium.
• Event hedge: purchase short-dated PLTR puts ahead of major EU/US regulatory milestones or key government budget votes (monitor 3–6 month windows) to insure against binary enforcement or procurement freezes; keep notional small but active across events.